"Receptors, Interleukin-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.
| Descriptor ID |
D017472
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.300
|
| Concept/Terms |
Receptors, Interleukin-1- Receptors, Interleukin-1
- Receptors, Interleukin 1
- IL1 Receptors
- Receptors, IL1
- Interleukin-1 Receptors
- Interleukin 1 Receptors
- Receptors, IL-1
- Receptors, IL 1
- IL-1 Receptors
- IL 1 Receptors
- Interleukin 1 Receptor
- Receptor, Interleukin 1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1".
This graph shows the total number of publications written about "Receptors, Interleukin-1" by people in this website by year, and whether "Receptors, Interleukin-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 9 | 5 | 14 |
| 2018 | 6 | 4 | 10 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 2 | 5 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-1" by people in Profiles.
-
Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysis. Rheumatology (Oxford). 2021 12 01; 60(12):5527-5537.
-
Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19. Cytokine. 2021 07; 143:155544.
-
An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19? Front Immunol. 2021; 12:631044.
-
Interleukin 1a: a comprehensive review on the role of IL-1a in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021 Mar; 20(3):102763.
-
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study. Crit Care. 2020 12 10; 24(1):688.
-
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. J Allergy Clin Immunol. 2021 Feb; 147(2):561-566.e4.
-
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality. J Cardiovasc Med (Hagerstown). 2020 09; 21(9):625-629.
-
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1623-1627.
-
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection. Ann Hematol. 2020 12; 99(12):2953-2956.
-
A plea for the pathogenic role of immune complexes in severe Covid-19. Clin Immunol. 2020 08; 217:108493.